Publication:
Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA<sup>2</sup>LEN)

Simple item page
dc.contributor.authorJ. Bousqueten_US
dc.contributor.authorP. Van Cauwenbergeen_US
dc.contributor.authorN. Aït Khaleden_US
dc.contributor.authorC. Bacherten_US
dc.contributor.authorC. E. Baena-Cagnanien_US
dc.contributor.authorJ. Boucharden_US
dc.contributor.authorC. Bunnagen_US
dc.contributor.authorG. W. Canonicaen_US
dc.contributor.authorK. H. Carlsenen_US
dc.contributor.authorY. Z. Chenen_US
dc.contributor.authorA. A. Cruzen_US
dc.contributor.authorA. Custovicen_US
dc.contributor.authorP. Demolyen_US
dc.contributor.authorR. Dubakieneen_US
dc.contributor.authorS. Durhamen_US
dc.contributor.authorW. Fokkensen_US
dc.contributor.authorP. Howarthen_US
dc.contributor.authorJ. Kempen_US
dc.contributor.authorM. L. Kowalskien_US
dc.contributor.authorV. Kvedarieneen_US
dc.contributor.authorB. Lipworthen_US
dc.contributor.authorR. Lockeyen_US
dc.contributor.authorV. Lunden_US
dc.contributor.authorS. Mavale-Manuelen_US
dc.contributor.authorE. O. Meltzeren_US
dc.contributor.authorJ. Mullolen_US
dc.contributor.authorR. Naclerioen_US
dc.contributor.authorK. Nekamen_US
dc.contributor.authorK. Ohtaen_US
dc.contributor.authorN. Papadopoulosen_US
dc.contributor.authorG. Passalacquaen_US
dc.contributor.authorR. Pawankaren_US
dc.contributor.authorT. Popoven_US
dc.contributor.authorP. Potteren_US
dc.contributor.authorD. Priceen_US
dc.contributor.authorG. Scaddingen_US
dc.contributor.authorF. E.R. Simonsen_US
dc.contributor.authorV. Spicaken_US
dc.contributor.authorE. Valovirtaen_US
dc.contributor.authorD. Y. Wangen_US
dc.contributor.authorB. Yawnen_US
dc.contributor.authorO. Yusufen_US
dc.contributor.otherCHU Montpellieren_US
dc.contributor.otherUniversiteit Genten_US
dc.contributor.otherThe Unionen_US
dc.contributor.otherUniversity Hospital of Ghenten_US
dc.contributor.otherUniversity of Cordobaen_US
dc.contributor.otherSaint Joseph's Hospital Hamiltonen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversita degli Studi di Genovaen_US
dc.contributor.otherUniversitetet i Osloen_US
dc.contributor.otherCapital Institute of Pediatricsen_US
dc.contributor.otherUniversidade Federal da Bahiaen_US
dc.contributor.otherUniversity of Manchesteren_US
dc.contributor.otherVilniaus universitetasen_US
dc.contributor.otherRoyal Brompton Hospitalen_US
dc.contributor.otherUniversity of Amsterdamen_US
dc.contributor.otherUniversity of Southamptonen_US
dc.contributor.otherUniversity of Lodzen_US
dc.contributor.otherUniversity of Dundeeen_US
dc.contributor.otherUniversity of South Florida, Tampaen_US
dc.contributor.otherUCLen_US
dc.contributor.otherUniversity of Maputoen_US
dc.contributor.otherAllergy and Asthma Medical Group and Research Centeren_US
dc.contributor.otherHospital Clinic Barcelonaen_US
dc.contributor.otherUniversity of Chicagoen_US
dc.contributor.otherBelgyógyászati Osztály/Polyclinic of the Hospitaller Brothersen_US
dc.contributor.otherTeikyo Universityen_US
dc.contributor.otherUniversity of Athensen_US
dc.contributor.otherNippon Medical Schoolen_US
dc.contributor.otherMedical University of Sofiaen_US
dc.contributor.otherUniversity of Cape Town Lung Instituteen_US
dc.contributor.otherUniversity of Aberdeenen_US
dc.contributor.otherRoyal National TNE Hospitalen_US
dc.contributor.otherUniversity of Manitobaen_US
dc.contributor.otherCzech Initiative for Asthmaen_US
dc.contributor.otherTurku Allergy Centeren_US
dc.contributor.otherNational University of Singaporeen_US
dc.contributor.otherUniversity of Minnesota Systemen_US
dc.contributor.otherAllergy and Asthma Clinicsen_US
dc.contributor.otherGA2LENen_US
dc.contributor.otherHopital Arnaud de Villeneuveen_US
dc.date.accessioned2018-08-20T07:01:01Z
dc.date.available2018-08-20T07:01:01Z
dc.date.issued2006-09-01en_US
dc.description.abstractThe pharmacologic treatment of allergic rhinitis proposed by ARIA is an evidence-based and step-wise approach based on the classification of the symptoms. The ARIA workshop, held in December 1999, published a report in 2001 and new information has subsequently been published. The initial ARIA document lacked some important information on several issues. This document updates the ARIA sections on the pharmacologic and anti-IgE treatments of allergic rhinitis. Literature published between January 2000 and December 2004 has been included. Only a few studies assessing nasal and non-nasal symptoms are presented as these will be discussed in a separate document. Copyright © Blackwell Munksgaard 2006.en_US
dc.identifier.citationAllergy: European Journal of Allergy and Clinical Immunology. Vol.61, No.9 (2006), 1086-1096en_US
dc.identifier.doi10.1111/j.1398-9995.2006.01144.xen_US
dc.identifier.issn13989995en_US
dc.identifier.issn01054538en_US
dc.identifier.other2-s2.0-33746785057en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/23313
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33746785057&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titlePharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA<sup>2</sup>LEN)en_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33746785057&origin=inwarden_US

Files

Collections

Scopus 2006-2010